检索结果 - Jeffrey A. Engelman

Refine Results
  1. 1
    <i>ALK</i> in Lung Cancer: Past, Present, and Future

    <i>ALK</i> in Lung Cancer: Past, Present, and Future 由 Alice T. Shaw, Jeffrey A. Engelman

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    SnapShot: Non-Small Cell Lung Cancer

    SnapShot: Non-Small Cell Lung Cancer 由 Rebecca S. Heist, Jeffrey A. Engelman

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics

    ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics 由 Carlos L. Arteaga, Jeffrey A. Engelman

    出版 2014
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    The Role of the ErbB Family Members in Non–Small Cell Lung Cancers Sensitive to Epidermal Growth Factor Receptor Kinase Inhibitors

    The Role of the ErbB Family Members in Non–Small Cell Lung Cancers Sensitive to Epidermal Growth Factor Receptor Kinase Inhibitors 由 Jeffrey A. Engelman, Lewis C. Cantley

    出版 2006
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer

    Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer 由 Jeffrey A. Engelman, Pasi A. Jänne

    出版 2008
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Chemoprevention Meets Glucose Control

    Chemoprevention Meets Glucose Control 由 Jeffrey A. Engelman, Lewis C. Cantley

    出版 2010
    获取全文
    Carta
    加到收藏夹
    Saved in:
  7. 7
    Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer

    Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer 由 Matthew J. Niederst, Jeffrey A. Engelman

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Potential Therapeutic Strategies to Overcome Acquired Resistance to BRAF or MEK Inhibitors in BRAF Mutant Cancers

    Potential Therapeutic Strategies to Overcome Acquired Resistance to BRAF or MEK Inhibitors in BRAF Mutant Cancers 由 Ryan B. Corcoran, Jeffrey Settleman, Jeffrey A. Engelman

    出版 2011
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  9. 9
    Genetic Changes in Squamous Cell Lung Cancer: A Review

    Genetic Changes in Squamous Cell Lung Cancer: A Review 由 Rebecca S. Heist, Lecia V. Sequist, Jeffrey A. Engelman

    出版 2012
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  10. 10
    The PI3K Pathway As Drug Target in Human Cancer

    The PI3K Pathway As Drug Target in Human Cancer 由 Kevin D. Courtney, Ryan B. Corcoran, Jeffrey A. Engelman

    出版 2010
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    Specific Inhibitors of p38 Mitogen-activated Protein Kinase Block 3T3-L1 Adipogenesis

    Specific Inhibitors of p38 Mitogen-activated Protein Kinase Block 3T3-L1 Adipogenesis 由 Jeffrey A. Engelman, Michael P. Lisanti, Philipp E. Scherer

    出版 1998
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics

    The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics 由 Aaron N. Hata, Jeffrey A. Engelman, Anthony C. Faber

    出版 2015
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  13. 13
    Overcoming resistance to tyrosine kinase inhibitors: Lessons learned from cancer cells treated with EGFR antagonists

    Overcoming resistance to tyrosine kinase inhibitors: Lessons learned from cancer cells treated with EGFR antagonists 由 Brent N. Rexer, Jeffrey A. Engelman, Carlos L. Arteaga

    出版 2009
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  14. 14
    Targeting the PI3K signaling pathway in cancer

    Targeting the PI3K signaling pathway in cancer 由 Kwok‐Kin Wong, Jeffrey A. Engelman, Lewis C. Cantley

    出版 2009
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  15. 15
    Genes encoding human caveolin‐1 and ‐2 are co‐localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers

    Genes encoding human caveolin‐1 and ‐2 are co‐localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers 由 Jeffrey A. Engelman, Xiao Lan Zhang, Michael P. Lisanti

    出版 1998
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    The present and future of PI3K inhibitors for cancer therapy

    The present and future of PI3K inhibitors for cancer therapy 由 Pau Castel, Eneda Toska, Jeffrey A. Engelman, Maurizio Scaltriti

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Tyrosine kinase gene rearrangements in epithelial malignancies

    Tyrosine kinase gene rearrangements in epithelial malignancies 由 Alice T. Shaw, Peggy P. Hsu, Mark M. Awad, Jeffrey A. Engelman

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  18. 18
    Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav‐1, ‐2, and ‐3)

    Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav‐1, ‐2, and ‐3) 由 Jeffrey A. Engelman, Xiao Lan Zhang, Ferruccio Galbiati, Michael P. Lisanti

    出版 1998
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin

    Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin 由 Matthew G. Oser, Matthew J. Niederst, Lecia V. Sequist, Jeffrey A. Engelman

    出版 2015
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  20. 20
    Targeted Down-regulation of Caveolin-3 Is Sufficient to Inhibit Myotube Formation in Differentiating C2C12 Myoblasts

    Targeted Down-regulation of Caveolin-3 Is Sufficient to Inhibit Myotube Formation in Differentiating C2C12 Myoblasts 由 Ferruccio Galbiati, Daniela Volonté, Jeffrey A. Engelman, Philipp E. Scherer, Michael P. Lisanti

    出版 1999
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: